TSPO and glioblastoma: Several studies have shown that TSPO expression is elevated in cancer and correlate with poor survival in glioblastoma (30, 31), breast cancer (32, 33), prostate cancer (33, 34), liver cancer (35, 36), colorectal cancer (33, 37, 38), melanoma (39), and esophageal squamous cell carcinoma (40).